The results of hip and knee replacement surgery
are generally regarded as positive for patients. Nonetheless, they are
both major operations and have recognised complications. We present
a review of relevant claims made to the National Health Service
Litigation Authority. Between 1995 and 2010 there were 1004 claims
to a value of £41.5 million following hip replacement surgery and
523 claims to a value of £21 million for knee replacement. The most common
complaint after hip surgery was related to residual neurological
deficit, whereas after knee replacement it was related to infection.
Vascular complications resulted in the highest costs per case in
each group. Although there has been a large increase in the number of operations
performed, there has not been a corresponding relative increase
in litigation. The reasons for litigation have remained largely
unchanged over time after hip replacement. In the case of knee replacement,
although there has been a reduction in claims for infection, there
has been an increase in claims for technical errors. There has also
been a rise in claims for non-specified dissatisfaction. This information
is of value to surgeons and can be used to minimise the potential
mismatch between patient expectation, informed consent and outcome. Cite this article:
The product recall of Desmarquest Zirconia heads in 2001 was associated with specified batches of material. Despite of this fact, concerns raised over the stability of Zirconia led to a vast decrease in the use of Zirconia for hip prostheses. While there is evidence in the literature suggesting that Zirconia may become unstable, there remain many prostheses with Zirconia heads in use today. The purpose of this study was to report the condition observed in retrieved Zirconia heads not included in the product recall. The bearing surfaces of seven retrieved 22mm diameter Zirconia on UHMWPE hip prostheses were investigated to determine whether any degradation of the Zirconia occurred in-vivo. All seven of the Zirconia heads were manufactured by Saint-Gobain Cerammiques Avancees Desmarquest and implantation time varied from 1 to 10 years. Components were analysed by Talysurf, Interferometer, SEM and XRD and compared to new components. Talysurf of the components revealed an average surface roughness ranging from 0.004 to 0.007 micrometers Ra. This was only slightly rougher than new ceramic components which generally have an Ra of 0.003 micrometers. SEM of the surfaces did not reveal any difference between the retrieved components and new components. Further surface XRD of 4 of the 7 heads, as shown in Figure 1, showed very small percentages of monoclinic phase (28 degrees 2 theta) with predominantly tetragonal phase (30 degrees 2theta), similar to what is observed in new components. Figure 1: XRD of typical retrieved ZR head surface. All seven retrieved heads demonstrated no evidence suggesting that degradation of the Zirconia had occurred in-vivo.
A physiological hip simulator was used, loads and motions were applied to approximate